SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cardiology

• Publication date

  2016-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2015.12.008PMID 26730840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway.

  2015cited by this paper
• Protective effects of sirtuins in cardiovascular diseases: from bench to bedside

  2015cited by this paper
• The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling

  2015cited by this paper
• Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice

  2015cited by this paper
• The concomitant management of cancer therapy and cardiac therapy.

  2015cited by this paper
• SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells.

  2015cited by this paper
• Cardiotoxicity of anticancer treatments

  2015cited by this paper
• Resveratrol protects against doxorubicin‐induced cardiotoxicity in aged hearts through the SIRT1‐USP7 axis

  2015cited by this paper
• Acute coronary syndromes: Bivalirudin versus heparin for ACS

  2015cited by this paper
• Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

  2015cited by this paper
• Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats

  2014cited by this paper
• Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.

  2014cited by this paper
• Sirtuin 1 ablation in endothelial cells is associated with impaired angiogenesis and diastolic dysfunction.

  2014cited by this paper
• Dexrazoxane for reducing anthracycline-related cardiotoxicity in children with cancer: An update of the evidence

  2014cited by this paper
• Dynamic Changes in Myocardial Matrix and Relevance to Disease: Translational Perspectives

  2014cited by this paper
• Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study.

  2013cited by this paper
• Pharmacology at Work for Cardio-Oncology: Ranolazine to Treat Early Cardiotoxicity Induced by Antitumor Drugs

  2013cited by this paper
• Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.

  2013cited by this paper
• Doxorubicin induces senescence and impairs function of human cardiac progenitor cells

  2013cited by this paper
• Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.

  2013cited by this paper
• Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of

  2013cited by this paper
• The late effects of anticancer therapy after childhood Wilm's tumor: the role of diastolic function and ambulatory blood pressure monitoring.

  2013cited by this paper
• Anthracycline cardiotoxicity

  2012cited by this paper
• Identification of the molecular basis of doxorubicin-induced cardiotoxicity

  2012cited by this paper
• Chronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in rats

  2012cited by this paper
• Resveratrol

  2012cited by this paper
• Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats

  2012cited by this paper
• Interactions Between β-Catenin and Transforming Growth Factor-β Signaling Pathways Mediate Epithelial-Mesenchymal Transition and Are Dependent on the Transcriptional Co-activator cAMP-response Element-binding Protein (CREB)-binding Protein (CBP)*

  2012cited by this paper
• Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

  2011cited by this paper
• The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium.

  2011cited by this paper
• Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function

  2010cited by this paper
• Silent Information Regulator 1 Protects the Heart From Ischemia/Reperfusion

  2010cited by this paper
• Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.

  2010cited by this paper
• Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.

  2010cited by this paper
• Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3.

  2010cited by this paper
• Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer

  2009cited by this paper
• Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

  2009cited by this paper
• Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy

  2008cited by this paper
• Cardiovascular risk in long‐term survivors of testicular cancer

  2008cited by this paper
• Cardioprotective interventions for cancer patients receiving anthracyclines.

  2008cited by this paper
• Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart

  2007cited by this paper
• TGFbeta, cardiac fibroblasts, and the fibrotic response.

  2007cited by this paper
• American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects.

  2007cited by this paper
• Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.

  2007cited by this paper
• Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.

  2007cited by this paper
• TGFβ, cardiac fibroblasts, and the fibrotic response

  2007cited by this paper
• Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase.

  2006cited by this paper
• Protective effects of carvedilol against anthracycline-induced cardiomyopathy.

  2006cited by this paper
• Anthracycline cardiotoxicity

  2006cited by this paper
• Cardioprotective interventions for cancer patients receiving anthracyclines.

  2005cited by this paper
• Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function

  2004cited by this paper
• Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.

  2004cited by this paper
• The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.

  2004cited by this paper
• Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.

  2004cited by this paper
• Transforming Growth Factor-β Function Blocking Prevents Myocardial Fibrosis and Diastolic Dysfunction in Pressure-Overloaded Rats

  2002cited by this paper
• 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.

  2002cited by this paper
• Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart.

  2002cited by this paper
• Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.

  2001cited by this paper
• LATE CARDIAC DAMAGE OF ANTHRACYCLINE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDHOOD

  2000cited by this paper
• Adriamycin-induced heart failure: mechanisms and modulation

  2000cited by this paper
• Left Ventricular Diastolic Filling Patterns Associated with Progressive Anthracycline-Induced Myocardial Damage: A Prospective Study

  1999cited by this paper
• Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell.

  1998cited by this paper
• Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

  1997cited by this paper
• Myocardial fibrosis: functional significance and regulatory factors.

  1993cited by this paper

• Cellular crosstalk in doxorubicin-induced cardiotoxicity: underlying mechanisms and therapeutic strategies.

  2026cites this paper
• The copper transporter protein SLC31A1-mediated copper metabolism imbalance drives cuproptosis through the SIRT1/HMGB1 pathway in heart failure.

  2026cites this paper
• Aging hearts, fibrotic fears: The sirtuin connection.

  2025cites this paper
• Sirtuin-Mediated Modulation of Cardiac Fibrosis: Emerging Molecular Insights and Therapeutic Perspectives.

  2025cites this paper
• Sirtuins as Endogenous Regulators of Cardiac Fibrosis: A Current Perspective

  2025influential citation
• Cross-sectional analysis of fibrosis-related gene expression in drug-induced gingival enlargement associated with periodontitis.

  2025cites this paper
• Therapeutic potential and mechanistic insights of astragaloside IV in the treatment of arrhythmia: a comprehensive review

  2025cites this paper
• A simplified co-culture reveals altered cardiotoxic responses to doxorubicin in hPSC-derived cardiomyocytes in the presence of endothelial cells

  2025cites this paper
• Management of Cardiac Rhythm Disorders in Cardio-oncology

  2025cites this paper
• Atrial Cardiomyopathy-associated Arrhythmia and the Impact of Sirtuin Signaling Pathway: A Narrative Review.

  2025cites this paper
• Panax ginseng exerts cardioprotective effect post myocardial infarction by attenuating myocardial fibrosis and inflammation through SIRT1 signaling pathways

  2025cites this paper
• The FAK‐NRF2 Axis Alleviates DOX‐Induced Cardiotoxicity by Inhibiting Ferroptosis

  2025cites this paper
• Geneticin ameliorates pulmonary fibrosis by attenuating the TGF-β/Smad via modulating AMPK/SIRT1 signaling.

  2024cites this paper
• Sophocarpine alleviates doxorubicin-induced heart injury by suppressing oxidative stress and apoptosis

  2024cites this paper
• Targeting Cellular Senescence in Aging and Age-Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies

  2024cites this paper
• Doxorubicin-Induced Cardiotoxicity Through SIRT1 Loss Potentiates Overproduction of Exosomes in Cardiomyocytes

  2024cites this paper
• 5-Demethylnobiletin Ameliorates Isoproterenol-Induced Cardiac Fibrosis and Apoptosis by Repressing the Sirt1/FOXO3a/NF-κB and Wnt/β-Catenin Pathways.

  2024cites this paper
• Sex difference in human diseases: mechanistic insights and clinical implications

  2024cites this paper
• The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)

  2024cites this paper
• The Role of Circular RNA in the Pathogenesis of Chemotherapy-Induced Cardiotoxicity in Cancer Patients: Focus on the Pathogenesis and Future Perspective

  2024cites this paper
• Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells

  2024cites this paper
• An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity

  2024cites this paper
• Sophocarpine attenuates doxorubicin-induced heart injury through inhibition of fibrosis.

  2024cites this paper
• Early myocardial injury in children on doxorubicin for cancer chemotherapy: a cross-sectional study in a tertiary referral centre in Kenya

  2024cites this paper
• Single-Cell Transcriptomic Analysis Reveals Myocardial Fibrosis Mechanism of Doxorubicin-Induced Cardiotoxicity.

  2024cites this paper
• Nicotinamide Mononucleotide Supplementation Alleviates Doxorubicin-Induced Multi-Organ Fibrosis

  2024cites this paper
• Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms

  2023cites this paper
• Polyphenols as Potential Preventers of Osteoporosis: A Comprehensive Review on Antioxidant and Anti-inflammatory Effects, Molecular Mechanisms, and Signal Pathways in Bone Metabolism.

  2023cites this paper
• Poly (ADP-ribose) polymerase pathway inhibitor (Olaparib) upregulates SERCA2a expression and attenuates doxorubicin-induced cardiomyopathy in mice.

  2023cites this paper
• RGS7 balances acetylation/de-acetylation of p65 to control chemotherapy-dependent cardiac inflammation

  2023cites this paper
• Protection against cancer therapy-induced cardiovascular injury by planed-derived polyphenols and nanomaterials.

  2023cites this paper
• Protective effect of grape seed extract and exercise training on tissues toxicities in doxorubicin-treated healthy rat

  2023cites this paper
• Recent update on the protective potentials of resveratrol against cisplatin-induced ototoxicity: a systematic review.

  2023cites this paper
• Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs

  2023cites this paper
• Exercise reduces hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice via its effects against inflammation and oxidative stress

  2023cites this paper
• The role of Sirtuin 1 and its activators in age-related lung disease.

  2023cites this paper
• Molecular mechanisms of endothelial remodeling under doxorubicin treatment.

  2023cites this paper
• Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity

  2023cites this paper
• Increased Intracellular Free Zinc Has Pleiotropic Effects on Doxorubicin-Induced Cytotoxicity in hiPCS-CMs Cells

  2023cites this paper
• Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis

  2022cites this paper
• Moderate Wine Consumption and Health: A Narrative Review

  2022cites this paper
• Nicotinamide Mononucleotide Administration Prevents Doxorubicin-Induced Cardiotoxicity and Loss in Physical Activity in Mice

  2022cites this paper
• A RGS7-CaMKII complex drives myocyte-intrinsic and myocyte-extrinsic mechanisms of chemotherapy-induced cardiotoxicity

  2022cites this paper
• Intravenous Nicotinamide Riboside Administration Has a Cardioprotective Effect in Chronic Doxorubicin-Induced Cardiomyopathy

  2022cites this paper
• SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity

  2022influential citation
• Mechanisms and Drug Intervention for Doxorubicin-Induced Cardiotoxicity Based on Mitochondrial Bioenergetics

  2022cites this paper
• Emerging role of transient receptor potential (TRP) ion channels in cardiac fibroblast pathophysiology

  2022cites this paper
• Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology

  2022cites this paper
• Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway

  2022cites this paper
• Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments

  2022cites this paper
• Cardiac fibrosis in oncologic therapies.

  2022cites this paper
• The Scientific Rationale for the Introduction of Renalase in the Concept of Cardiac Fibrosis

  2022cites this paper
• Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2

  2022cites this paper
• Resveratrol ameliorates myocardial fibrosis by regulating Sirt1/Smad3 deacetylation pathway in rat model with dilated cardiomyopathy

  2022cites this paper
• Neferine attenuates doxorubicin‐induced fibrosis and hypertrophy in H9c2 cells

  2022cites this paper
• Pharmacological assessment of zebrafish-based cardiotoxicity models.

  2022cites this paper
• Role of ranolazine in heart failure: From cellular to clinic perspective.

  2022cites this paper
• Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction

  2021cites this paper
• Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways

  2021cites this paper
• MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway

  2021cites this paper
• A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis

  2021cites this paper
• Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction

  2021cites this paper
• Role of sirtuins in cardiovascular diseases

  2021cites this paper
• Molecular mechanisms of anthracycline cardiovascular toxicity.

  2021cites this paper
• Fibrosis: Sirtuins at the checkpoints of myofibroblast differentiation and profibrotic activity

  2021cites this paper
• Resveratrol and endothelial function: a literature review.

  2021cites this paper
• Translational Proteomics Analysis of Anthracycline-Induced Cardiotoxicity From Cardiac Microtissues to Human Heart Biopsies

  2021cites this paper
• Resveratrol Confers Protection Against Ischemia/Reperfusion Injury by Increase of Angiotensin (1-7) Expression in a Rat Model of Myocardial Hypertrophy

  2021cites this paper
• Dual integrin αvβ3 and αvβ5 blockade attenuates cardiac dysfunction by reducing fibrosis in a rat model of doxorubicin-induced cardiomyopathy

  2021cites this paper
• Role of acetylation in doxorubicin-induced cardiotoxicity

  2021cites this paper
• A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities

  2021influential citation
• Epigenetic regulation in fibrosis progress.

  2021cites this paper
• Apolipoprotein E4 Is Associated with Right Ventricular Dysfunction in Dilated Cardiomyopathy—An Animal and In-Human Comparative Study

  2021cites this paper
• Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis

  2021cites this paper
• Heart function assessment during aging in apolipoprotein E knock-out mice

  2021cites this paper
• Resveratrol against Cardiac Fibrosis: Research Progress in Experimental Animal Models

  2021cites this paper
• Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents

  2021cites this paper
• Protective effects and mechanisms of psoralidin against adriamycin-induced cardiotoxicity

  2021cites this paper
• Assessing Doxorubicin-Induced Cardiomyopathy by 99mTc-3PRGD2 Scintigraphy Targeting Integrin αvβ3 in a Rat Model

  2021influential citation
• MicroRNA‐129‐1‐3p protects cardiomyocytes from pirarubicin‐induced apoptosis by down‐regulating the GRIN2D‐mediated Ca2+ signalling pathway

  2020cites this paper
• CYP1B1 as a therapeutic target in cardio-oncology

  2020cites this paper
• Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy.

  2020cites this paper
• Preventing and Treating Anthracycline Cardiotoxicity: New Insights.

  2020cites this paper
• Mechanosensing dysregulation in the fibroblast: a hallmark of the aging heart.

  2020cites this paper
• A short review: Doxorubicin and its effect on cardiac proteins

  2020cites this paper
• Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity

  2020cites this paper
• Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity

  2020cites this paper
• Natural Products as Modulators of Sirtuins

  2020cites this paper
• Nicotinamide Riboside—The Current State of Research and Therapeutic Uses

  2020cites this paper
• Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1/AKT/Bcl-2 signalling pathway

  2020cites this paper
• Regulation of left atrial fibrosis induced by mitral regurgitation by SIRT1

  2020cites this paper
• Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients

  2020cites this paper
• Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression

  2020cites this paper
• Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?

  2020cites this paper
• Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity

  2020cites this paper
• The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

  2020cites this paper
• Signaling Pathways Underlying Anthracycline Cardiotoxicity

  2020cites this paper
• Anthracycline-Induced Cardiotoxicity: Time to Focus on Cardioprotection Again.

  2019cites this paper
• Impact of corvitin and alpha-ketoglutarate on heart morphology, expression and activity of matrix metalloproteinases 2/9 in the heart of rats with doxorubicin-induced cardiomyopathy

  2019cites this paper
• Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway

  2019cites this paper